The global gene expression market size was USD 13.47 billion in 2023, calculated at USD 14.88 billion in 2024 and is expected to reach around USD 40.4 billion by 2034, expanding at a CAGR of 10.5% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Gene Expression Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Gene Expression Market Revenue and Volume Forecast, by Process, 2024-2034
8.1.1. Sample collection
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Purification
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Data analysis and interpretation
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. PCR analysis
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. cDNA synthesis
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Gene Expression Market Revenue and Volume Forecast, by Product, 2024-2034
9.1.1. Instruments
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Reagents and Consumables
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Services
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Gene Expression Market Revenue and Volume Forecast, by Capacity, 2024-2034
10.1.1. Low- to Mid-Plex
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. High-Plex
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1. Gene Expression Market Revenue and Volume Forecast, by End User, 2024-2034
11.1.1. Pharmaceutical and biotechnology companies
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Diagnostic Laboratories
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1.3. Academic Research Centers
11.1.3.1. Market Revenue and Volume Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.1.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.1.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.1.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.1.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.1.5.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.1.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.1.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.1.6.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.1.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.2.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.2.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.2.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.5.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.2.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.2.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.6.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.2.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.2.7.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.7.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.2.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.2.8.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.8.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.2.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.3.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.3.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.3.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.5.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.3.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.3.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.6.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.3.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.3.7.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.7.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.3.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.3.8.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.8.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.3.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.4.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.4.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.5.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.4.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.4.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.6.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.4.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.4.7.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.7.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.4.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.4.8.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.8.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.4.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.5.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.5.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.5.5.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.5.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Process (2021-2034)
12.5.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)
12.5.6.3. Market Revenue and Volume Forecast, by Capacity (2021-2034)
12.5.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)
13.1. QIAGEN
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Quest Diagnostics, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. F. Hoffmann-La Roche Ltd.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Illumina, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. PerkinElmer, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Bio-Rad Laboratories
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Thermo Fisher Scientific, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Agilent Technologies
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. GE Healthcare
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Promega Corp.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample